Prognosis of Children Undergoing Liver Transplantation: A 30-Year European Study

医学 肝移植 回顾性队列研究 儿科 存活率 器官共享联合网络 移植 内科学 外科
作者
Ulrich Baumann,Vincent Karam,René Adam,Constantino Fondevila,Anil Dhawan,Etienne Sokal,Emmanuel Jacquemin,Deirdre Kelly,Enke Grabhorn,Joanna Pawłowska,Lorenzo D'Antiga,Paloma Jara Vega,Dominique Debray,Wojciech G. Polak,Jean de Ville de Goyet,Henkjan J. Verkade
出处
期刊:Pediatrics [American Academy of Pediatrics]
卷期号:150 (4) 被引量:5
标识
DOI:10.1542/peds.2022-057424
摘要

OBJECTIVES The European Liver Transplant Registry has been collecting data on virtually all pediatric liver transplant (PLT) procedures in Europe since 1968. We analyzed patient outcome over time and identified parameters associated with long-term patient outcome. METHODS Participating centers and European organ-sharing organizations provided retrospective data to the European Liver Transplant Registry. To identify trends, data were grouped into consecutive time spans: era A: before 2000, era B: 2000 to 2009, and the current era, era C: since 2010. RESULTS From June 1968 until December 2017, 16 641 PLT were performed on 14 515 children by 133 centers. The children <7 years of age represented 58% in era A, and 66% in the current era (P <.01). The main indications for PLT were congenital biliary diseases (44%) and metabolic diseases (18%). Patient survival at 5 years is currently 86% overall and 97% in children who survive the first year after PLT. The survival rate has improved from 74% in era A to 83% in era B and 85% in era C (P <.0001). Low-volume centers (<5 PLT/year) represented 75% of centers but performed only 19% of PLT and were associated with a decreased survival rate. In the current era, however, survival rates has become irrespective of volume. Infection is the leading cause of death (4.1%), followed by primary nonfunction of the graft (1.4%). CONCLUSIONS PLT has become a highly successful medical treatment that should be considered for all children with end-stage liver disease. The main challenge for further improving the prognosis remains the early postoperative period.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI

祝大家在新的一年里科研腾飞
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
lanlan发布了新的文献求助10
刚刚
达斯维达!完成签到,获得积分0
1秒前
2秒前
钟叉烧发布了新的文献求助10
2秒前
英俊的铭应助xqq采纳,获得30
4秒前
可耐的威发布了新的文献求助10
4秒前
winter完成签到 ,获得积分10
5秒前
lincanmou发布了新的文献求助10
8秒前
科研通AI2S应助小新采纳,获得10
10秒前
香蕉觅云应助chen采纳,获得10
12秒前
xinnnnya完成签到,获得积分10
13秒前
模糊中正应助光亮妙之采纳,获得10
14秒前
阿浮发布了新的文献求助10
15秒前
tgoutgou发布了新的文献求助10
16秒前
lincanmou完成签到,获得积分10
17秒前
17秒前
英俊的铭应助科研通管家采纳,获得10
19秒前
peili应助科研通管家采纳,获得30
19秒前
从容芮应助科研通管家采纳,获得50
19秒前
从容芮应助科研通管家采纳,获得50
20秒前
20秒前
20秒前
劲秉应助wanghaha采纳,获得10
20秒前
20秒前
飞快的珩完成签到 ,获得积分10
21秒前
快乐平露发布了新的文献求助10
21秒前
lwk205完成签到,获得积分0
21秒前
chen完成签到,获得积分10
23秒前
充电宝应助理想三寻采纳,获得10
23秒前
张张完成签到,获得积分20
25秒前
chen发布了新的文献求助10
25秒前
lanlan完成签到 ,获得积分10
25秒前
大个应助111111采纳,获得10
26秒前
微笑的如之完成签到,获得积分10
27秒前
张张发布了新的文献求助10
29秒前
钟叉烧完成签到,获得积分10
30秒前
酷波er应助光亮妙之采纳,获得10
31秒前
深情安青应助陈伊森采纳,获得10
33秒前
咖啡博士完成签到,获得积分10
34秒前
SciGPT应助lena采纳,获得10
34秒前
高分求助中
Востребованный временем 2500
诺贝尔奖与生命科学 2000
Aspects of Babylonian celestial divination: the lunar eclipse tablets of Enūma Anu Enlil 1000
Kidney Transplantation: Principles and Practice 1000
Field Guide to Insects of South Africa 660
The Three Stars Each: The Astrolabes and Related Texts 500
Separation and Purification of Oligochitosan Based on Precipitation with Bis(2-ethylhexyl) Phosphate Anion, Re-Dissolution, and Re-Precipitation as the Hydrochloride Salt 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 物理化学 催化作用 细胞生物学 免疫学 冶金
热门帖子
关注 科研通微信公众号,转发送积分 3380048
求助须知:如何正确求助?哪些是违规求助? 2995423
关于积分的说明 8763378
捐赠科研通 2680443
什么是DOI,文献DOI怎么找? 1467961
科研通“疑难数据库(出版商)”最低求助积分说明 678810
邀请新用户注册赠送积分活动 670803